awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36892821-42F67E3D-D250-4280-B0AF-131FAA51C8BA
Q36892821-42F67E3D-D250-4280-B0AF-131FAA51C8BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36892821-42F67E3D-D250-4280-B0AF-131FAA51C8BA
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer.
P2860
Q36892821-42F67E3D-D250-4280-B0AF-131FAA51C8BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36892821-42F67E3D-D250-4280-B0AF-131FAA51C8BA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3b675a22222dcaa9e3c6e4887071717b4ae13aac
P2860
The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab.